Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive Bladder Cancer”

633 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 633 results

Not applicableStudy completedNCT05822518
What this trial is testing

Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

Who this might be right for
Cancer, BladderCystostomy; Complications
Menoufia University 42
Testing effectiveness (Phase 2)Looking for participantsNCT03609216
What this trial is testing

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma
Alliance for Clinical Trials in Oncology 271
Not applicableStudy completedNCT05675176
What this trial is testing

Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
National and Kapodistrian University of Athens 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588179
What this trial is testing

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

Who this might be right for
NMIBC
Fudan University 58
Large-scale testing (Phase 3)Looking for participantsNCT06929286
What this trial is testing

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 125
Testing effectiveness (Phase 2)Looking for participantsNCT07296705
What this trial is testing

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital 25
Not applicableStudy completedNCT03327883
What this trial is testing

Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)UnknownNCT04859751
What this trial is testing

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Qilu Pharmaceutical Co., Ltd. 53
Testing effectiveness (Phase 2)Looking for participantsNCT02138734
What this trial is testing

Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
ImmunityBio, Inc. 596
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Active Not RecruitingNCT06253845
What this trial is testing

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT04172675
What this trial is testing

Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT06059547
What this trial is testing

Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerAdult Solid Tumor
CatalYm GmbH 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04960709
What this trial is testing

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 712
Testing effectiveness (Phase 2)UnknownNCT03993249
What this trial is testing

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Who this might be right for
Bladder Cancer
Hellenic GenitoUrinary Cancer Group 78
Very early researchStudy completedNCT04897763
What this trial is testing

Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 6
Large-scale testing (Phase 3)Looking for participantsNCT06493552
What this trial is testing

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Who this might be right for
Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 700
Large-scale testing (Phase 3)Study completedNCT00330707
What this trial is testing

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
National University Hospital, Singapore 140
Early research (Phase 1)Looking for participantsNCT05839119
What this trial is testing

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Who this might be right for
Urothelial Carcinoma BladderAndrogen Receptor Positive
Brown University 32
Load More Results